A new trading day began on Friday, with Biodesix Inc (NASDAQ: BDSX) stock price down -23.53% from the previous day of trading, before settling in for the closing price of $1.70. BDSX’s price has ranged from $1.15 to $2.21 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 24.79%. Meanwhile, its annual earnings per share averaged 45.63%. With a float of $76.49 million, this company’s outstanding shares have now reached $96.24 million.
Let’s determine the extent of company efficiency that accounts for 217 employees. In terms of profitability, gross margin is 84.1%, operating margin of -52.71%, and the pretax margin is -66.84%.
Biodesix Inc (BDSX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Biodesix Inc is 47.31%, while institutional ownership is 37.02%. The most recent insider transaction that took place on Aug 09 ’24, was worth 248. In this transaction Chief Accounting Officer of this company sold 155 shares at a rate of $1.60, taking the stock ownership to the 11,242 shares. Before that another transaction happened on Aug 12 ’24, when Company’s Chief Accounting Officer sold 54 for $1.57, making the entire transaction worth $85. This insider now owns 11,188 shares in total.
Biodesix Inc (BDSX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 45.63% per share during the next fiscal year.
Biodesix Inc (NASDAQ: BDSX) Trading Performance Indicators
Here are Biodesix Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.30. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.39, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.22 in one year’s time.
Technical Analysis of Biodesix Inc (BDSX)
Looking closely at Biodesix Inc (NASDAQ: BDSX), its last 5-days average volume was 0.17 million, which is a jump from its year-to-date volume of 0.15 million. As of the previous 9 days, the stock’s Stochastic %D was 52.50%. Additionally, its Average True Range was 0.10.
During the past 100 days, Biodesix Inc’s (BDSX) raw stochastic average was set at 2.63%, which indicates a significant decrease from 4.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 114.81% in the past 14 days, which was higher than the 61.59% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7199, while its 200-day Moving Average is $1.6023. However, in the short run, Biodesix Inc’s stock first resistance to watch stands at $1.5533. Second resistance stands at $1.8067. The third major resistance level sits at $1.9433. If the price goes on to break the first support level at $1.1633, it is likely to go to the next support level at $1.0267. Now, if the price goes above the second support level, the third support stands at $0.7733.
Biodesix Inc (NASDAQ: BDSX) Key Stats
With a market capitalization of 144.32 million, the company has a total of 145,177K Shares Outstanding. Currently, annual sales are 49,090 K while annual income is -52,150 K. The company’s previous quarter sales were 17,930 K while its latest quarter income was -10,810 K.
